1-108918719-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_013296.5(GPSM2):​c.1370C>T​(p.Thr457Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0159 in 1,612,994 control chromosomes in the GnomAD database, including 558 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.032 ( 166 hom., cov: 31)
Exomes 𝑓: 0.014 ( 392 hom. )

Consequence

GPSM2
NM_013296.5 missense

Scores

1
17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.277

Publications

10 publications found
Variant links:
Genes affected
GPSM2 (HGNC:29501): (G protein signaling modulator 2) The protein encoded by this gene belongs to a family of proteins that modulate activation of G proteins, which transduce extracellular signals received by cell surface receptors into integrated cellular responses. The N-terminal half of this protein contains 10 copies of leu-gly-asn (LGN) repeat, and the C-terminal half contains 4 GoLoco motifs, which are involved in guanine nucleotide exchange. This protein may play a role in neuroblast division and in the development of normal hearing. Mutations in this gene are associated with autosomal recessive nonsyndromic deafness (DFNB82). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2016]
CLCC1 (HGNC:29675): (chloride channel CLIC like 1) Predicted to enable chloride channel activity. Predicted to be involved in chloride transport. Located in endoplasmic reticulum and mitochondria-associated endoplasmic reticulum membrane. Implicated in retinitis pigmentosa 32. [provided by Alliance of Genome Resources, Apr 2022]
AKNAD1 (HGNC:28398): (AKNA domain containing 1) This gene encodes a protein which contains a domain found in an AT-hook-containing transcription factor. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2012]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.001593709).
BP6
Variant 1-108918719-C-T is Benign according to our data. Variant chr1-108918719-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 45564.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0763 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GPSM2NM_013296.5 linkc.1370C>T p.Thr457Met missense_variant Exon 12 of 15 ENST00000264126.9 NP_037428.3 P81274A0A024R0F8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GPSM2ENST00000264126.9 linkc.1370C>T p.Thr457Met missense_variant Exon 12 of 15 1 NM_013296.5 ENSP00000264126.3 P81274

Frequencies

GnomAD3 genomes
AF:
0.0314
AC:
4781
AN:
152080
Hom.:
165
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0783
Gnomad AMI
AF:
0.00329
Gnomad AMR
AF:
0.0166
Gnomad ASJ
AF:
0.0297
Gnomad EAS
AF:
0.0141
Gnomad SAS
AF:
0.0605
Gnomad FIN
AF:
0.00217
Gnomad MID
AF:
0.0570
Gnomad NFE
AF:
0.0105
Gnomad OTH
AF:
0.0263
GnomAD2 exomes
AF:
0.0209
AC:
5258
AN:
251392
AF XY:
0.0220
show subpopulations
Gnomad AFR exome
AF:
0.0762
Gnomad AMR exome
AF:
0.0106
Gnomad ASJ exome
AF:
0.0305
Gnomad EAS exome
AF:
0.0170
Gnomad FIN exome
AF:
0.00152
Gnomad NFE exome
AF:
0.0105
Gnomad OTH exome
AF:
0.0201
GnomAD4 exome
AF:
0.0143
AC:
20888
AN:
1460796
Hom.:
392
Cov.:
30
AF XY:
0.0155
AC XY:
11279
AN XY:
726782
show subpopulations
African (AFR)
AF:
0.0758
AC:
2532
AN:
33422
American (AMR)
AF:
0.0117
AC:
524
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.0294
AC:
767
AN:
26124
East Asian (EAS)
AF:
0.0155
AC:
616
AN:
39652
South Asian (SAS)
AF:
0.0539
AC:
4648
AN:
86216
European-Finnish (FIN)
AF:
0.00204
AC:
109
AN:
53418
Middle Eastern (MID)
AF:
0.0373
AC:
215
AN:
5760
European-Non Finnish (NFE)
AF:
0.00927
AC:
10295
AN:
1111132
Other (OTH)
AF:
0.0196
AC:
1182
AN:
60354
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.453
Heterozygous variant carriers
0
1019
2038
3058
4077
5096
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
472
944
1416
1888
2360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0315
AC:
4797
AN:
152198
Hom.:
166
Cov.:
31
AF XY:
0.0320
AC XY:
2383
AN XY:
74420
show subpopulations
African (AFR)
AF:
0.0786
AC:
3262
AN:
41516
American (AMR)
AF:
0.0165
AC:
253
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.0297
AC:
103
AN:
3468
East Asian (EAS)
AF:
0.0141
AC:
73
AN:
5182
South Asian (SAS)
AF:
0.0602
AC:
290
AN:
4820
European-Finnish (FIN)
AF:
0.00217
AC:
23
AN:
10602
Middle Eastern (MID)
AF:
0.0578
AC:
17
AN:
294
European-Non Finnish (NFE)
AF:
0.0106
AC:
718
AN:
68002
Other (OTH)
AF:
0.0260
AC:
55
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
226
452
679
905
1131
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
62
124
186
248
310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0172
Hom.:
140
Bravo
AF:
0.0335
TwinsUK
AF:
0.00971
AC:
36
ALSPAC
AF:
0.0127
AC:
49
ESP6500AA
AF:
0.0744
AC:
328
ESP6500EA
AF:
0.00988
AC:
85
ExAC
AF:
0.0226
AC:
2742
Asia WGS
AF:
0.0420
AC:
146
AN:
3478
EpiCase
AF:
0.0136
EpiControl
AF:
0.0122

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Mar 14, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

May 07, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Thr457Met in Exon 12 of GPSM2: This variant is not expected to have clinical sig nificance because it has been identified in 7.2% (270/3738) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http: //evs.gs.washington.edu/EVS; dbSNP rs35089879). -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 12, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Chudley-McCullough syndrome Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.078
BayesDel_addAF
Benign
-0.36
T
BayesDel_noAF
Benign
-0.23
CADD
Benign
18
DANN
Benign
0.97
DEOGEN2
Benign
0.055
T;T;T
Eigen
Benign
-0.67
Eigen_PC
Benign
-0.58
FATHMM_MKL
Benign
0.090
N
LIST_S2
Uncertain
0.87
.;.;D
MetaRNN
Benign
0.0016
T;T;T
MetaSVM
Benign
-0.61
T
MutationAssessor
Benign
0.34
N;N;N
PhyloP100
0.28
PrimateAI
Benign
0.39
T
PROVEAN
Benign
-0.78
N;.;N
REVEL
Benign
0.16
Sift
Benign
0.081
T;.;T
Sift4G
Benign
0.083
T;.;T
Polyphen
0.24
B;B;B
Vest4
0.070
MPC
0.25
ClinPred
0.0045
T
GERP RS
1.4
Varity_R
0.016
gMVP
0.31
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35089879; hg19: chr1-109461341; API